MEDICINOVA INC (MNOV)
2025-06-30 | 2025-03-31 | 2024-09-30 | ||
|---|---|---|---|---|
| Revenues | 134,599 | - | - | |
| Costs of services | 116,349 | - | - | |
| General and administrative | 1,436,690 | 1,362,708 | 1,449,728 | |
| Research, development and patents | 2,188,652 | 1,839,802 | 1,859,400 | |
| Total operating expenses | 3,741,691 | 3,202,510 | 3,309,128 | |
| Operating loss | -3,607,092 | -3,202,510 | -3,309,128 | |
| Interest income | 324,955 | 336,111 | 447,847 | |
| Other income (expense), net | 952 | 2,279 | 9,102 | |
| Net loss | -3,281,185 | -2,864,120 | -2,852,179 | |
| Foreign currency translation adjustments | 2,681 | 5,102 | 7,724 | |
| Comprehensive loss | -3,278,504 | -2,859,018 | -2,844,455 | |
| Earnings per share, basic | -0.07 | -0.06 | -0.06 | |
| Earnings per share, diluted, total | -0.07 | -0.06 | -0.06 | |
| Weighted average number of shares outstanding, basic, total | 49,046,246 | 49,046,246 | 49,046,246 | |
| Weighted average number of shares outstanding, diluted, total | 49,046,246 | 49,046,246 | 49,046,246 | |